TOFACITINIB INTERMEDIATES

VIDGASTECH provides Tofacitinib Intermediates with superior purity and stability, supporting the synthesis of JAK inhibitors for autoimmune disease treatment.

Additional Content with Keywords:
VIDGASTECH specializes in pharmaceutical-grade Tofacitinib API intermediates, essential for the production of JAK inhibitors used in rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis treatment. With strict GMP compliance, high-purity synthesis, and quality control, our intermediates ensure efficiency in immunosuppressive drug development. As a trusted supplier of Tofacitinib intermediates, we cater to global pharmaceutical companies developing targeted therapies for autoimmune diseases. Contact us for bulk API intermediates and custom synthesis solutions.

4-chloro-7H-pyrrolo[2 ,3- d]pyrimidine 3680-69-1
27 (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3- amine 477600-70-7
28 (Methoxymethyl)triphenylphosphonium chloride 4009-98-7
29 (3R,4R)-N,4-Dimethyl-1- (phenylmethyl)- 3-
piperidinamine hydrochloride
1062580-52-2
30 4-chloro-7-tosyl-7-H-pyrrolo[2,3- d]pyrimidine 479633-63-1
TOFACITINIB
31 N-((3R,4R)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-
pyrrolo[2,3-d]pyrimidin-4-amine
477600-73-0
32 N-Methyl-N-((3R,4R)-4-methylpiperidin-3- yl)-7H-
pyrrolo[2,3-d]pyrimidin-4-amine
477600-74-1
33 Ethyl 2 –cyano-4,4- diethoxybutanoate 52133-67-2
34 Benzyl-N,4-dimethylpiperidine-3- amine dihydrochloride 1228879-37-5